Company logo

SHL - Sonic Healthcare Limited

ASX -> Healthcare -> Diagnostics & Research
Sydney, Australia
Type: Equity

SHL price evolution
SHL
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Current assets
Cash $645 $645 $619.61
Short term investments
Net receivables $6494 $6256 $1072.9
Inventory $4721 $4636 $212.66
Total current assets $14187 $14246 $2037.5
Long term investments $198.35 $198.35 $170.69
Property, plant & equipment $4385 $4217 $2857.02
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $46626 $46342 $13768.34
Current liabilities
Accounts payable $1993 $2022 $2061
Deferred revenue
Short long term debt $661.03 $661.03 $800.74
Total current liabilities $11167 $10836 $2174.17
Long term debt $14420 $14038 $3188.8
Total noncurrent liabilities
Total debt
Total liabilities $28390 $27708 $5866.11
Shareholders' equity
Retained earnings $1614 $2206 $3443.65
Other shareholder equity $102 -$45 $429.6
Total shareholder equity $8075.12 $8075.12 $7902.23
(in millions $) 30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Jun 2021
Current assets
Cash $645 $797.99 $780 $899.83
Short term investments
Net receivables $1362.18 $1022.18 $1217.46 $1088.72
Inventory $208.83 $199.2 $216.19 $224.39
Total current assets $2353 $2133.17 $2305.91 $2284.57
Long term investments $198.35 $175.8 $145.22 $108.11
Property, plant & equipment $3051.88 $2798.11 $2624.86 $2552.92
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $14826.47 $13014.63 $12552.01 $11760.99
Current liabilities
Accounts payable $255.8 $243.8 $1026.54
Deferred revenue
Short long term debt $661.03 $346.79 $342.08 $551.43
Total current liabilities $2322.19 $1878.34 $2084.27 $2217.94
Long term debt $3854.34 $2753.69 $2670.88 $2683.38
Total noncurrent liabilities
Total debt
Total liabilities $6751.35 $5092.77 $5123.84 $5376.01
Shareholders' equity
Retained earnings $3552.28 $3554.2 $3351.02 $2303.01
Other shareholder equity $381.94 $525.24 $216.21 $70.87
Total shareholder equity $8075.12 $7921.86 $7428.17 $6384.99
(in millions $) 31 Jan 2025 30 Oct 2024 30 Jul 2024 1 May 2024
Revenue
Total revenue $5423 $5435
Cost of revenue
Gross Profit $2090 $2006
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1410 $1416
Operating income
Income from continuing operations
EBIT
Income tax expense $122 $110
Interest expense -$89 -$81
Net income
Net income $469 $426
Income (for common shares)
(in millions $) 30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Jun 2021
Revenue
Total revenue $8967.4 $8168.95 $9340.15 $8754.12
Cost of revenue $6022.88 $5326.53 $5613.91 $1616.83
Gross Profit $2944.53 $2842.42 $3726.24 $7137.29
Operating activities
Research & development
Selling, general & administrative $249.79 $217.02 $270.76 $3958.81
Total operating expenses $8117.75 $7150.74 $7179.78 $6833.01
Operating income $849.66 $1018.21 $2160.37 $1921.11
Income from continuing operations
EBIT
Income tax expense $186.85 $223.26 $561.74 $480.94
Interest expense -$151.35 -$87.02 -$79.82
Net income
Net income $511.09 $684.98 $1460.57 $1315.04
Income (for common shares) $511.09 $684.98 $1460.57 $1315.04
(in millions $) 30 Jun 2024 1 May 2024 31 Dec 2023 30 Oct 2023
Net income $154.39 $101.16
Operating activities
Depreciation $175.52 $191.83
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $225.92
Investing activities
Capital expenditures -$112.22
Investments
Total cash flows from investing -$332 -$590.72 -$1069
Financing activities
Dividends paid -$146.96 -$1066
Sale and purchase of stock $73.41
Net borrowings $363.42
Total cash flows from financing -$231 $286.69 -$690
Effect of exchange rate -$35 -$155
Change in cash and equivalents $58 -$89.19 $205
(in millions $) 30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Oct 2021
Net income $511.09 $684.98 $1460.57
Operating activities
Depreciation $694.39 $631.3 $608.51
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $2225.82
Investing activities
Capital expenditures -$286.95
Investments
Total cash flows from investing -$989.18 -$14140
Financing activities
Dividends paid -$455.4 -$856
Sale and purchase of stock -$253.73
Net borrowings -$624.69
Total cash flows from financing -$1349.29 $11839
Effect of exchange rate $34
Change in cash and equivalents -$119.83 $666
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.84
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A